{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:02:14Z","timestamp":1789128134860,"version":"build-2803163510"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5,1]]},"DOI":"10.1097\/qai.0000000000000095","type":"journal-article","created":{"date-parts":[[2013,12,30]],"date-time":"2013-12-30T17:18:15Z","timestamp":1388423895000},"page":"25-32","source":"Crossref","is-referenced-by-count":10,"title":["Regulatory T Cells and the Risk of CMV End-Organ Disease in Patients With AIDS"],"prefix":"10.1097","volume":"66","author":[{"given":"Adriana","family":"Weinberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Tovar-Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance A.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann C.","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Zolopa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy M.","family":"Gulick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Polsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejo","family":"Erice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210131","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1086\/375843","article-title":". Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360).","volume":"37","author":"Erice","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R2-4-20210131","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.qai.0000155204.96973.c3","article-title":". Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies.","volume":"38","author":"Wohl","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R4-4-20210131","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/S0140-6736(04)16500-8","article-title":". Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy.","volume":"363","author":"Deayton","year":"2004","journal-title":"Lancet"},{"key":"R5-4-20210131","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1182\/blood-2002-08-2502","article-title":". Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4 T cells in protection against CMV disease.","volume":"101","author":"Gamadia","year":"2003","journal-title":"Blood"},{"key":"R6-4-20210131","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood-2005-11-012864","article-title":". Prospective simultaneous quantification of human cytomegalovirus-specific CD4 and CD8 T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants.","volume":"108","author":"Lilleri","year":"2006","journal-title":"Blood"},{"key":"R7-4-20210131","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1084\/jem.20042384","article-title":". Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells.","volume":"201","author":"Bunde","year":"2005","journal-title":"J Exp Med"},{"key":"R8-4-20210131","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1084\/jem.20042408","article-title":". Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease.","volume":"201","author":"Sacre","year":"2005","journal-title":"J Exp Med"},{"key":"R9-4-20210131","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1182\/blood-2003-02-0420","article-title":". Ex vivo characterization of human CD8 T subsets with distinct replicative history and partial effector functions.","volume":"102","author":"Rufer","year":"2003","journal-title":"Blood"},{"key":"R10-4-20210131","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.4049\/jimmunol.173.3.1834","article-title":". Emergence of a CD4CD28- granzyme B, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection.","volume":"173","author":"van Leeuwen","year":"2004","journal-title":"J Immunol"},{"key":"R11-4-20210131","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1128\/JVI.77.9.5226-5240.2003","article-title":". Ex vivo profiling of CD8-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers.","volume":"77","author":"Elkington","year":"2003","journal-title":"J Virol"},{"key":"R12-4-20210131","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":". Broadly targeted human cytomegalovirus-specific CD4 and CD8 T cells dominate the memory compartments of exposed subjects.","volume":"202","author":"Sylwester","year":"2005","journal-title":"J Exp Med"},{"key":"R13-4-20210131","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1097\/00002030-200311210-00006","article-title":". Cytomegalovirus-specific IFN-gamma production is associated with protection against cytomegalovirus reactivation in HIV-infected patients on highly active antiretroviral therapy.","volume":"17","author":"Weinberg","year":"2003","journal-title":"AIDS"},{"key":"R14-4-20210131","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1086\/499826","article-title":". Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapy.","volume":"193","author":"Weinberg","year":"2006","journal-title":"J Infect Dis"},{"key":"R15-4-20210131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/JVI.01768-07","article-title":". Natural regulatory T cells and persistent viral infection.","volume":"82","author":"Li","year":"2008","journal-title":"J Virol"},{"key":"R16-4-20210131","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.4049\/jimmunol.173.4.2211","article-title":"Regulatory cells and infectious agents: detentes cordiale and contraire.","volume":"173","author":"Rouse","year":"2004","journal-title":"J Immunol"},{"key":"R17-4-20210131","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1086\/523651","article-title":". Functional suppression by FoxP3CD4CD25(high) regulatory T cells during acute hepatitis C virus infection.","volume":"197","author":"Smyk-Pearson","year":"2008","journal-title":"J Infect Dis"},{"key":"R18-4-20210131","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.4049\/jimmunol.179.7.4323","article-title":". CD8 CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers.","volume":"179","author":"Filaci","year":"2007","journal-title":"J Immunol"},{"key":"R19-4-20210131","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.4049\/jimmunol.1003812","article-title":"Suppressive CD8 T cells arise in the absence of CD4 help and compromise control of persistent virus.","volume":"186","author":"Molloy","year":"2011","journal-title":"J Immunol"},{"key":"R20-4-20210131","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1182\/blood-2003-04-1320","article-title":". Human CD8CD25 thymocytes share phenotypic and functional features with CD4CD25 regulatory thymocytes.","volume":"102","author":"Cosmi","year":"2003","journal-title":"Blood"},{"key":"R21-4-20210131","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":". CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4 T reg cells.","volume":"203","author":"Liu","year":"2006","journal-title":"J Exp Med"},{"key":"R22-4-20210131","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1182\/blood-2010-12-323162","article-title":". Regulatory T cells control HIV replication in activated T cells through a cAMP-dependent mechanism.","volume":"117","author":"Moreno-Fernandez","year":"2011","journal-title":"Blood"},{"key":"R23-4-20210131","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.4049\/jimmunol.174.4.1783","article-title":". Cutting edge: contact-mediated suppression by CD4CD25 regulatory cells involves a granzyme B-dependent, perforin-independent mechanism.","volume":"174","author":"Gondek","year":"2005","journal-title":"J Immunol"},{"key":"R24-4-20210131","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.4049\/jimmunol.175.11.7093","article-title":"IMs Rifa, Shi Z, et al.. Cutting edge: CD8CD122 regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8 T cells.","volume":"175","author":"Endharti","year":"2005","journal-title":"J Immunol"},{"key":"R25-4-20210131","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.4049\/jimmunol.174.10.5907","article-title":"License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC.","volume":"174","author":"Vlad","year":"2005","journal-title":"J Immunol"},{"key":"R26-4-20210131","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.4049\/jimmunol.174.6.3143","article-title":". The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients.","volume":"174","author":"Andersson","year":"2005","journal-title":"J Immunol"},{"key":"R27-4-20210131","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.4049\/jimmunol.174.3.1446","article-title":"Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-beta.","volume":"174","author":"Rao","year":"2005","journal-title":"J Immunol"},{"key":"R28-4-20210131","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.virol.2009.11.038","article-title":". Regulatory function of cytomegalovirus-specific CD4CD27-CD28- T cells.","volume":"398","author":"Tovar-Salazar","year":"2010","journal-title":"Virology"},{"key":"R29-4-20210131","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa030264","article-title":". Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection.","volume":"349","author":"Robbins","year":"2003","journal-title":"N Engl J Med"},{"key":"R30-4-20210131","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1056\/NEJMoa030265","article-title":". Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection.","volume":"349","author":"Shafer","year":"2003","journal-title":"N Engl J Med"},{"key":"R31-4-20210131","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/377311","article-title":". A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease.","volume":"188","author":"Fischl","year":"2003","journal-title":"J Infect Dis"},{"key":"R32-4-20210131","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jama.288.2.169","article-title":". Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial.","volume":"288","author":"Hammer","year":"2002","journal-title":"JAMA"},{"key":"R33-4-20210131","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1310\/hct0904-269","article-title":". AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics.","volume":"9","author":"Smurzynski","year":"2008","journal-title":"HIV Clin Trials"},{"key":"R34-4-20210131","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1310\/hct1003-143","article-title":". Low rate of CMV end-organ disease in HIV-infected patients despite low CD4 cell counts and CMV viremia: results of ACTG protocol A5030.","volume":"10","author":"Wohl","year":"2009","journal-title":"HIV Clin Trials"},{"key":"R35-4-20210131","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1056\/NEJMoa031772","article-title":". Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection.","volume":"350","author":"Gulick","year":"2004","journal-title":"N Engl J Med"},{"key":"R36-4-20210131","doi-asserted-by":"crossref","first-page":"e5575","DOI":"10.1371\/journal.pone.0005575","article-title":". Early antiretroviral therapy reduces AIDS progressiondeath in individuals with acute opportunistic infections: a multicenter randomized strategy trial.","volume":"4","author":"Zolopa","year":"2009","journal-title":"PLoS One"},{"key":"R37-4-20210131","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jim.2010.09.032","article-title":". Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays.","volume":"363","author":"Weinberg","year":"2010","journal-title":"J Immunol Methods"},{"key":"R38-4-20210131","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1172\/JCI24685","article-title":". The role of 2 FOXP3 isoforms in the generation of human CD4 Tregs.","volume":"115","author":"Allan","year":"2005","journal-title":"J Clin Invest"},{"key":"R39-4-20210131","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/eji.200636435","article-title":". Transient expression of FOXP3 in human activated nonregulatory CD4 T cells.","volume":"37","author":"Wang","year":"2007","journal-title":"Eur J Immunol"},{"key":"R40-4-20210131","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1182\/blood-2012-05-431023","article-title":". A novel function for FOXP3 in humans: intrinsic regulation of conventional T cells.","volume":"121","author":"McMurchy","year":"2013","journal-title":"Blood"},{"key":"R41-4-20210131","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1172\/JCI28941","article-title":". Human CD4 CD25hi Foxp3 regulatory T cells are derived by rapid turnover of memory populations in vivo.","volume":"116","author":"Vukmanovic-Stejic","year":"2006","journal-title":"J Clin Invest"},{"key":"R42-4-20210131","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1172\/JCI19441","article-title":". Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4CD25- T cells.","volume":"112","author":"Walker","year":"2003","journal-title":"J Clin Invest"},{"key":"R43-4-20210131","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1182\/blood-2004-03-0859","article-title":". Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells.","volume":"104","author":"Grossman","year":"2004","journal-title":"Blood"},{"key":"R44-4-20210131","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1182\/blood-2009-07-235382","article-title":". Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion.","volume":"115","author":"Jahrsdorfer","year":"2010","journal-title":"Blood"},{"key":"R45-4-20210131","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2005-11-4502","article-title":". Activated CD4CD25 T cells selectively kill B lymphocytes.","volume":"107","author":"Zhao","year":"2006","journal-title":"Blood"},{"key":"R46-4-20210131","first-page":"49","article-title":"Velilla PA, et al..","volume":"28","author":"Moreno-Fernandez","year":"2012","journal-title":"cAMP during HIV infection: friend or foe AIDS Res Hum Retroviruses"},{"key":"R47-4-20210131","doi-asserted-by":"crossref","first-page":"e28118","DOI":"10.1371\/journal.pone.0028118","article-title":". Frequency of circulating regulatory T cells increases during chronic HIV infection and is largely controlled by highly active antiretroviral therapy.","volume":"6","author":"Presicce","year":"2011","journal-title":"PLoS One"},{"key":"R48-4-20210131","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1128\/JVI.06251-11","article-title":". CD4 CD25 regulatory T cells impair HIV-1-specific CD4 T cell responses by upregulating interleukin-10 production in monocytes.","volume":"86","author":"Kwon","year":"2012","journal-title":"J Virol"},{"key":"R49-4-20210131","doi-asserted-by":"crossref","first-page":"e11762","DOI":"10.1371\/journal.pone.0011762","article-title":". FOXP3 expression is upregulated in CD4T cells in progressive HIV-1 infection and is a marker of disease severity.","volume":"5","author":"Suchard","year":"2010","journal-title":"PLoS One"},{"key":"R50-4-20210131","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.4049\/jimmunol.171.12.6323","article-title":"The regulatory T cell family: distinct subsets and their interrelations.","volume":"171","author":"Jonuleit","year":"2003","journal-title":"J Immunol"},{"key":"R51-4-20210131","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.virusres.2010.09.010","article-title":"Role of CMV in immune senescence.","volume":"157","author":"Pawelec","year":"2011","journal-title":"Virus Res"},{"issue":"Suppl 7","key":"R52-4-20210131","doi-asserted-by":"crossref","first-page":"S754","DOI":"10.1093\/clinids\/12.Supplement_7.S754","article-title":"Impact of cytomegalovirus infection on organ transplant recipients.","volume":"12","author":"Rubin","year":"1990","journal-title":"Rev Infect Dis"},{"key":"R53-4-20210131","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1001\/jama.1989.03420240121038","article-title":"The indirect effects of cytomegalovirus infection on the outcome of organ transplantation.","volume":"261","author":"Rubin","year":"1989","journal-title":"JAMA"},{"key":"R54-4-20210131","first-page":"99","article-title":"Cytomegalovirus infection and atherosclerosis.","volume":"5","author":"Adam","year":"1997","journal-title":"Cent Eur J Public Health"},{"key":"R55-4-20210131","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/QAD.0b013e328351f780","article-title":". A role for cytomegalovirus-specific CD4CX3CR1 T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis.","volume":"26","author":"Sacre","year":"2012","journal-title":"AIDS"},{"key":"R56-4-20210131","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1086\/525853","article-title":". Poor predictive value of cytomegalovirus (CMV)-specific T cell assays for the development of CMV retinitis in patients with AIDS.","volume":"46","author":"Jacobson","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R57-4-20210131","doi-asserted-by":"crossref","first-page":"e43937","DOI":"10.1371\/journal.pone.0043937","article-title":". An analysis of regulatory T-cell and Th-17 cell dynamics during cytomegalovirus replication in solid organ transplant recipients.","volume":"7","author":"Egli","year":"2012","journal-title":"PLoS One"},{"key":"R58-4-20210131","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1128\/JVI.01715-09","article-title":". Gut mucosal FOXP3 regulatory CD4 T cells and Nonregulatory CD4 T cells are differentially affected by simian immunodeficiency virus infection in rhesus macaques.","volume":"84","author":"Allers","year":"2010","journal-title":"J Virol"},{"key":"R59-4-20210131","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/aid.2008.0140","article-title":". Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression.","volume":"25","author":"Cao","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R60-4-20210131","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1097\/QAD.0b013e32825eab8b","article-title":". Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.","volume":"21","author":"Lim","year":"2007","journal-title":"AIDS"},{"key":"R61-4-20210131","doi-asserted-by":"crossref","first-page":"e15924","DOI":"10.1371\/journal.pone.0015924","article-title":". A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers.","volume":"6","author":"Hunt","year":"2011","journal-title":"PLoS One"},{"key":"R62-4-20210131","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/QAI.0b013e31817bbea5","article-title":". The relationship of T-regulatory cell subsets to disease stage, immune activation, and pathogen-specific immunity in HIV infection.","volume":"48","author":"Tenorio","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R63-4-20210131","doi-asserted-by":"crossref","first-page":"8307","DOI":"10.1128\/JVI.00520-08","article-title":". Preservation of FoxP3 regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4 T-cell activation.","volume":"82","author":"Chase","year":"2008","journal-title":"J Virol"},{"key":"R64-4-20210131","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1097\/QAD.0b013e328319edc0","article-title":". HIV-specific regulatory T cells are associated with higher CD4 cell counts in primary infection.","volume":"22","author":"Kared","year":"2008","journal-title":"AIDS"},{"key":"R65-4-20210131","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/QAI.0b013e31822ccfcc","article-title":". Disease-modifying therapeutic concepts for HIV in the era of highly active antiretroviral therapy.","volume":"58","author":"Butler","year":"2011","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAI.0000000000000095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:37:06Z","timestamp":1620970626000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201405010-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0000000000000095","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5,1]]}}}